Brussels, 23/07/2013 (Agence Europe) - On 22 July, the European Commission conditionally authorised acquisition of Swedish dialysis equipment manufacturer Gambro by rival healthcare company Baxter of the United States. The Commission had concerns that the transaction as originally notified on 3 June would have reduced effective competition on the market for continuous renal therapy technology (CRRT) in a large number of member states, but the commitments submitted by Baxter adequately...